Altamira Therapeutics Ltd. (CYTOF) Operating income 2022–2024
Altamira Therapeutics Ltd. (CYTOF) annual operating income history from SEC filings — each fiscal year as reported.
-$6.9MFY2024 · since FY2022: -$18.9M → -$6.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$6.9M | -4.0% |
| FY2023 | -$6.6M | +65.1% |
| FY2022 | -$18.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice